13F
中

OGN ORGANON & CO

2026Q1 · CUSIP 68622V106 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
602
Δ holders QoQ
-29
Breadth percentile
Top 95%
Whale holders
183
Δ whales
-1
Inst. holding value
$1.2B
New positions
82
Closed positions
111
Price momentum (1Q)
+85.1%
Put / Call
9/13

Breadth history (34 quarters)

2021Q2: Δ+958 · h=959 2021Q3: Δ-55 · h=904 2021Q4: Δ-17 · h=887 2022Q1: Δ-91 · h=796 2022Q2: Δ+39 · h=835 2022Q3: Δ-62 · h=773 2022Q4: Δ+37 · h=810 2023Q1: Δ-58 · h=752 2023Q2: Δ-36 · h=716 2023Q3: Δ+3 · h=719 2023Q4: Δ-10 · h=709 2024Q1: Δ+2 · h=711 2024Q2: Δ+5 · h=716 2024Q3: Δ-4 · h=712 2024Q4: Δ+27 · h=739 2025Q1: Δ-27 · h=712 2025Q2: Δ-22 · h=690 2025Q3: Δ-25 · h=665 2025Q4: Δ-34 · h=631 2026Q1: Δ-29 · h=602 2021Q2: holders=959 2021Q3: holders=904 2021Q4: holders=887 2022Q1: holders=796 2022Q2: holders=835 2022Q3: holders=773 2022Q4: holders=810 2023Q1: holders=752 2023Q2: holders=716 2023Q3: holders=719 2023Q4: holders=709 2024Q1: holders=711 2024Q2: holders=716 2024Q3: holders=712 2024Q4: holders=739 2025Q1: holders=712 2025Q2: holders=690 2025Q3: holders=665 2025Q4: holders=631 2026Q1: holders=602 -958 -479 +0 +479 +958 5417741007 21Q221Q422Q222Q423Q223Q424Q224Q425Q225Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 4 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q4 Top 19% -40.7% -38.8%
2022Q4 Top 10% -15.7% -6.2%
2022Q2 Top 2% -19.6% -5.0%
2021Q2 Top 0% -1.0% +1.9%

Options Sentiment

Put holders
9
QoQ: -2
Call holders
13
QoQ: -2

See methodology →

Fundamentals

PE (TTM)
14.4
EPS (TTM)
$0.94
EPS YoY
-67.4%
Revenue (TTM)
$6.2B
Revenue YoY
-2.1%
Quarterly Revenue & EPS (4Y)
2022-06-30: $1.6B 2022-09-30: $1.5B 2022-12-31: $1.5B 2023-03-31: $1.5B 2023-06-30: $1.6B 2023-09-30: $1.5B 2023-12-31: $1.6B 2024-03-31: $1.6B 2024-06-30: $1.6B 2024-09-30: $1.6B 2024-12-31: $1.6B 2025-03-31: $1.5B 2025-06-30: $1.6B 2025-09-30: $1.6B 2025-12-31: $1.5B 2026-03-31: $1.5B 2022-06-30: EPS 0.92 2022-09-30: EPS 0.89 2022-12-31: EPS 0.42 2023-03-31: EPS 0.69 2023-06-30: EPS 0.95 2023-09-30: EPS 0.23 2023-12-31: EPS 2.12 2024-03-31: EPS 0.78 2024-06-30: EPS 0.75 2024-09-30: EPS 1.38 2024-12-31: EPS 0.42 2025-03-31: EPS 0.33 2025-06-30: EPS 0.56 2025-09-30: EPS 0.61 2025-12-31: EPS -0.78 2026-03-31: EPS 0.55 0B 0.8B 1.6B $B -0.86 0.74 2.33 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 5 2023-03-31: PE 6.22023-06-30: PE 6.82023-09-30: PE 4.42023-12-31: PE 4.32024-03-31: PE 52024-06-30: PE 52024-09-30: PE 2.92024-12-31: PE 4.52025-03-31: PE 3.12025-06-30: PE 3.52025-09-30: PE 3.92025-12-31: PE 10.22026-03-31: PE 14.3 3 9 15 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)